Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Off-label Ruling’s Potential Fallout Is “Terrifying,” FDA’s Temple Says

Executive Summary

If firms could promote drugs for uses not backed by well-controlled studies, it would be “a nightmare,” Temple says; AEI’s Scott Gottlieb suggests the agency might try to regulate how medicines are prescribed.

You may also be interested in...



Amarin's First Amendment Victory Could Cut Both Ways For Industry

Companies will have to weigh prospect of freer discussion with health care providers about off-label uses with the risk that FDA and the courts will not see their statements as truthful and non-misleading.

Amarin's First Amendment Victory Could Cut Both Ways For Industry

Companies will have to weigh prospect of freer discussion with health care providers about off-label uses with the risk that FDA and the courts will not see their statements as truthful and non-misleading.

Off-Label Promotion Ruling Presents Hidden Risks For Pharma Companies, Lawyers Say

An appeals court ruling that bars prosecution solely for speech promoting off-label use carries with it potential negative ramifications for the pharmaceutical industry, including liability under state consumer protection laws and greater government scrutiny of internal marketing documents.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

LL111799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel